Oncomine Dx Target Test Multi-CDx (FF)（Suspended beyond orders placed 08-10-2023）

TOP
gene-related test
genetic tests for malignant tumor (solid tumor)
Oncomine Dx Target Test Multi-CDx (FF)（Suspended beyond orders placed 08-10-2023）

Laboratory：Akiruno

○Oncomine Dx Target Test Multi-CDx (FF)（Suspended beyond orders placed 08-10-2023）

CODE：00E55 6

TEST NAME SPECIMEN
REQUIREMENT
（ｍL） CONTAINER CAP COLOR STORE
TEMPERATURE
(STABILITY) TURNAROUND
TIME (DAY) METHODOLOGY REFERENCE RANGE
(UNIT)
Oncomine Dx Target Test Multi-CDx (FF)（Suspended beyond orders placed 08-10-2023）
tissue
ARR
6-11 Next Generation Sequencing (NGS)
A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments.

COMMENT

The purpose of this study is to analyze BRAF V600E mutation, EGFR gene mutation, ALK fusion gene, ROS1 fusion gene, and RET fusion gene in genomic DNA and RNA extracted from cancer tissue to determine the indication of the drugs listed in the attached table for patients with non-small cell lung cancer.
The available days are Monday to Friday. Please make sure that the material contains the tumor site before submitting it.
Please avoid duplicate requests with other items. Since this test method is more susceptible to contamination, please handle the specimens with care when collecting them.
When requesting this test, please be sure to also request the nucleic acid extraction item (item code No.: M961 0).
●About materials other than tissues
Please place the collected pleural fluid, alveolar lavage fluid, and bronchial lavage fluid for abrasion in the designated container (ARR), centrifuge (760G (2000-3000rpm) x 10 minutes) at room temperature, remove as much of the supernatant as possible, and submit the sediment after freezing it.
●Notes
After collecting the specimen, please process it immediately. Please note that if the number of cells in the submitted specimen is low, the test may not be possible.

CONTAINER

ARR 旧容器記号 r A

滅菌ポリスピッツ

貯蔵方法：室温

TEST DIRECTORY